Tissue engineering of heart valves: Decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells

Circulation

Volumn 111, Issue 21, 2005, Pages 2792-2797

  Rieder, Erwin ^a   Seebacher, Gernot ^a   Kasimir, Marie Theres ^a   Eichmair, Eva ^a   Winter, Birgitta ^a   Dekan, Barbara ^a   Wolner, Ernst ^a   Simon, Paul ^a   Weigel, Guenter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Immunology; Inflammation; Tissue engineering; Valves

Indexed keywords

MUSCLE PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL MIGRATION; CELL STRAIN U937; HEART VALVE PROSTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR WEIGHT; MONOCYTE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PULMONARY VALVE; SWINE; TISSUE ENGINEERING; TISSUE HOMOGENATE;

ANIMALS; CELL LINE; CELL MOVEMENT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEART VALVES; HUMANS; MONOCYTES; PROTEINS; SPECIES SPECIFICITY; SWINE; TISSUE ENGINEERING;

EID: 20344375233     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.473629     Document Type: Article

References (28)

1. Schoen FJ, Levy RJ. Heart valve bioprostheses: antimineralization. Eur J Cardiothoracic Surg. 1992;6:S91-S94.
2. 3. Am J Pathol. 1991;138:971-981.
3. Mohler ER III, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscl Throm Vasc Biol. 1997;17:547-552.
4. Elkins RC, Dawson PE, Goldstein S, Walsh SP, Black KS. Decellularized human valve allografts. Ann Thorac Surg. 2001;71(suppl):S428-S432.
5. Dohmen PM, Lembeke A, Hotz H, Kivelitz D, Konertz WF. Ross operation with a tissue engineered heart valve. Ann Thorac Surg. 2002; 74:1438-1442.
6. Rieder E, Kasimir MT, Silberhumer G, Seebacher G, Wolner E, Simon P, Weigel G. Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg. 2004;172:399-405.
7. Sundstroem C, Nilson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937) Int J Cancer. 1976;17:565-577.
8. Spinier A, Willheim M, Leutmezer F, Ohler R, Krugluger W, Reissner C, Lucas T, Brodowitz T, Roth E, Boltz-Nitulescu G. Effects of 1 alpha,25-dihydroxyvitamin D3 and cytokines on the expression of MHC antigens, complement receptors and other antigens on human blood monocytes and U-937 cells: role in cell differentiation, activation and phagocytosis. Immunology. 1997;90:286-293.
9. Kim MK, Herrera GA, Battarbee HD. Role of glutaraldehyde in calcification of porcine aortic valve fibroblasts. Am J Pathol. 1999;154: 843-852.
10. Kim KM. Cells, rather than extracellular matrix, nucleate apatite in glutaraldehyde-treated vascular tissue. J Biomed Mater Res. 2002;59: 639-645.
11. Schoen FJ, Levy RJ, Nelson AC, Bernhard WF, Nashef A, Hawley M. Onset and progression of experimental bioprosthetic heart valve calcification. Lab Invest. 1985;52:523-532.
12. Human P, Zilla P. Characterization of the immune response to valve bioprostheses and its role in primary tissue failure. Ann Thorac Surg. 2001;71:S385-S388.
13. Hogan P, Duplock L, Green M, Smith S, Gall KL, Frazer IH, O'Brien MF. Human aortic valve allografts elicit a donor-specific immune response. J Thorac Cardiovasc Surg. 1996;112:1260-1266.
14. Hoekstra FM, Witvliet M, Knoop CY, Wassenaar C, Bogers AJ, Weimar W, Claas FH. Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies. Ann Thorac Surg. 1998;66:2022-2026.
15. O'Brien MF, Goldstein S, Walsh S, Black KS, Elkins R, Clarke D. The Synergraft: a new acellular (non-GA-fixed) tissue heart valve for autologous recellularization: first experimental studies before clinical implantation. Semin Thorac Cardiovasc Surg. 1999;11(suppl 1):194-200.
16. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti JP, Mayer JE Jr. Tissue-engineered valve conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000;119(pt 1):732-740.
17. Hoerstrup SP, Sodian R, Daebritz S, Wang J, Bacha EA, Martin DP, Moran AM, Guleserian KJ, Sperling JS, Kaushal S, Vacanti JP, Schoen FJ, Mayer JE Jr. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(suppl):III-44-III-49.
18. Cebotari S. Mertsching H, Kallenbach K, Kostin S, Repin O, Batrinac A, Kleczka C, Ciubotaru A, Haverich A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation. 2002; 106(suppl 1):I-63-I-68.
19. Hawkins JA, Human ND, Lambert L, Jones J, Di Russo GB, Profaizer T, Fuller TC, Minich LL, Williams RV, Shaddy RE. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J Thorac Cardiovasc Surg. 2003;126:247-253.
20. Sievers HH, Stierle U, Schmidtke C, Bechtel M. Decellularized pulmonary homograft (SynerGraft) for reconstruction of the right ventricular outflow tract: first clinical experience. Z Kardiol. 2003;92:53-59.
21. Elkins RC, Lane MM, Capps SB, McCue C, Dawson PE. Humoral immune response to allograft valve tissue pretreated with an antigen reduction process. Semin Thorac Cardiovasc Surg. 2001;13(suppl 1):82-86.
22. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve Synergraft™ in pediatric patients. Eur J Cardiothorac Surg. 2003;23:1002-1006.
23. Fernandez-Botran R, Gorantla V, Sun X, Ren X, Perez-Abadia G, Crespo FA, Oliver R, Orhun HI, Quan EE, Maldonado C, Ray M, Barker JH. Targeting of glycosaminoglycan-cytokine interaction as a novel therapeutic approach in allotransplantation. Transplantation. 2002;74: 623-629.
24. Siminoesco DT, Lovekamp JJ, Vyavahare NR. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration. J Heart Valve Dis. 2003;12:217-225.
25. Wilhelmi MH, Rebe P, Leyh R, Wilhelmi M, Haverich A, Mertsching H. Role of inflammation and ischemia after implantation of xenogeneic pulmonary valve conduits: histological evaluation after 6 to 12 months in sheep. Int J Artif Organs. 2003;26:411-420.
26. Caterina MJ, Devreotes PN. Molecular insights into eukaryotic chemotaxis. FASEB J. 1991;5:3078-3085.
27. Kew RR, Peng T, DiMartino SJ, Madhavan D, Weinmann SJ, Cheng D, Prossnitz ER. Undifferentiated U-937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J Leukoc Biol. 1997;61: 329-337.
28. Koolbergen DR, Hazekamp MG, de Heer E. The pathology of fresh and cryopreserved homograft heart valves: an analysis of forty explanted homograft valves. J Thorac Cardiovasc Surg. 2002;124:689-697.